NantKwest's Patrick Soon-Shiong on reverse merger with ImmunityBio

NantKwest announces a reverse merger with a frequent collaborator ImmunityBio in a stock-for-stock deal. Patrick Soon-Shiong, NantKwest executive chairman and NantWorks chairman and CEO, joins CNBC's "Squawk on the Street" to discuss.